Blueshift Asset Management LLC Purchases New Shares in The Cooper Companies, Inc. (NASDAQ:COO)

Blueshift Asset Management LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,568 shares of the medical device company's stock, valued at approximately $696,000.

A number of other hedge funds also recently bought and sold shares of the company. Fulton Bank N.A. boosted its stake in shares of Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after purchasing an additional 109 shares in the last quarter. Torray Investment Partners LLC boosted its position in Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after buying an additional 132 shares during the period. Mather Group LLC. grew its stake in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after buying an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its position in Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after acquiring an additional 136 shares during the last quarter. Finally, Greenleaf Trust increased its stake in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock worth $268,000 after buying an additional 139 shares during the period. Institutional investors own 24.39% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

COO has been the subject of a number of analyst reports. Robert W. Baird dropped their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. reduced their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. StockNews.com cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Piper Sandler reiterated an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Stifel Nicolaus decreased their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Price Performance

Cooper Companies stock traded up $2.36 during mid-day trading on Monday, hitting $84.07. The stock had a trading volume of 2,343,447 shares, compared to its average volume of 1,287,611. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm's 50 day moving average is $89.90 and its 200 day moving average is $97.88. The firm has a market capitalization of $16.81 billion, a P/E ratio of 43.11, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.